{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:44:19Z","timestamp":1793400259875,"version":"4.5.0"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T00:00:00Z","timestamp":1701648000000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence Reports"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.dadr.2023.100209","type":"journal-article","created":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T18:37:39Z","timestamp":1701801459000},"page":"100209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Prevalence of xylazine among people who inject drugs seeking medical care at a syringe services program clinic: Miami, Florida, 2023"],"prefix":"10.1016","volume":"9","author":[{"given":"Maia H.","family":"Hauschild","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peyton V.","family":"Warp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hansel E.","family":"Tookes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ella","family":"Yakir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bharat","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subul","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrus","family":"Owens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Edward","family":"Suarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Serota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler S.","family":"Bartholomew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dadr.2023.100209_bib0001","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.2105\/AJPH.2022.306881","article-title":"Xylazine and overdoses: trends, concerns, and recommendations","volume":"112","author":"Alexander","year":"2022","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.dadr.2023.100209_bib0002","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1016\/j.jaad.2023.04.009","article-title":"Skin ulcerations caused by xylazine: a lesser-known entity","volume":"89","author":"Bishnoi","year":"2023","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.dadr.2023.100209_bib0003","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/j.1360-0443.2012.03803.x","article-title":"The rising prevalence of prescription opioid injection and its association with hepatitis C incidence among street-drug users: prescription opioid injection and HCV incidence","volume":"107","author":"Bruneau","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.dadr.2023.100209_bib0004","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/ADM.0000000000000955","article-title":"Management of xylazine withdrawal in a hospitalized patient: a case report","volume":"16","author":"Ehrman-Dupre","year":"2022","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.dadr.2023.100209_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2021.111083","article-title":"Analysis of drug residue in needle-exchange syringes in Washington, DC","volume":"329","author":"Evans","year":"2021","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.dadr.2023.100209_bib0006","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.cca.2021.07.010","article-title":"High prevalence of xylazine among fentanyl screen-positive urines from hospitalized patients, Philadelphia, 2021","volume":"521","author":"Korn","year":"2021","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.dadr.2023.100209_bib0007","series-title":"Evaluation of Xylazine Test Strips (BTNX) For Drug Checking Purposes","author":"Krotulski","year":"2023"},{"key":"10.1016\/j.dadr.2023.100209_bib0008","unstructured":"Polsky T.S., Berman L., Book L., 2023. CS\/CB 164: controlled substance testing. https:\/\/www.flsenate.gov\/Session\/Bill\/2023\/164\/BillText\/er\/PDF."},{"key":"10.1016\/j.dadr.2023.100209_bib0009","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1111\/1556-4029.15375","article-title":"Prevalence of xylazine in overdose cases: an analysis of Miami-Dade County medical examiner case data","volume":"68","author":"Potoukian","year":"2023","journal-title":"J. Forensic Sci."},{"key":"10.1016\/j.dadr.2023.100209_bib0010","doi-asserted-by":"crossref","first-page":"937","DOI":"10.4155\/bio.09.81","article-title":"False-positive' and 'false-negative' test results in clinical urine drug testing","volume":"1","author":"Reisfield","year":"2009","journal-title":"Bioanalysis"},{"key":"10.1016\/j.dadr.2023.100209_bib0011","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s11524-011-9662-6","article-title":"The emerging of xylazine as a new drug of abuse and its health consequences among drug users in Puerto Rico","volume":"89","author":"Reyes","year":"2012","journal-title":"J. Urban Health"},{"key":"10.1016\/j.dadr.2023.100209_bib0012","doi-asserted-by":"crossref","first-page":"458","DOI":"10.15585\/mmwr.mm7217a2","article-title":"Rapid analysis of drugs: a pilot surveillance system to detect changes in the illicit drug supply to guide timely harm reduction responses - eight syringe services programs, Maryland, November 2021-August 2022","volume":"72","author":"Russell","year":"2023","journal-title":"MMWR Morb. Mortal Wkly. Rep."},{"key":"10.1016\/j.dadr.2023.100209_bib0013","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/jat\/bku075","article-title":"False-positive interferences of common urine drug screen immunoassays: a review","volume":"38","author":"Saitman","year":"2014","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.dadr.2023.100209_bib0014","first-page":"885","article-title":"A review of the physiological effects of alpha2-agonists related to the clinical use of medetomidine in small animal practice","volume":"44","author":"Sinclair","year":"2003","journal-title":"Can. Vet. J."},{"key":"10.1016\/j.dadr.2023.100209_bib0015","unstructured":"The White House, 2023a. Biden\u2013Harris administration designates fentanyl combined with xylazine as an emerging threat to the United States | ONDCP. Accessed August 6, 2023. https:\/\/www.whitehouse.gov\/ondcp\/briefing-room\/2023\/04\/12\/biden-harris-administration-designates-fentanyl-combined-with-xylazine-as-an-emerging-threat-to-the-united-states\/."},{"key":"10.1016\/j.dadr.2023.100209_bib0016","unstructured":"The White House, 2023b. Fentanyl adulterated or associated with xylazine response plan. Office of National Drug Control Policy. Accessed September 8, 2023. https:\/\/www.whitehouse.gov\/wp-content\/uploads\/2023\/07\/FENTANYL-ADULTERATED-OR-ASSOCIATED-WITH-XYLAZINE-EMERGING-THREAT-RESPONSE-PLAN-Report-July-2023.pdf."},{"key":"10.1016\/j.dadr.2023.100209_bib0017","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1186\/s12889-021-11243-4","article-title":"The potential impacts of community drug checking within the overdose crisis: qualitative study exploring the perspective of prospective service users","volume":"21","author":"Wallace","year":"2021","journal-title":"BMC Public Health"}],"container-title":["Drug and Alcohol Dependence Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772724623000793?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772724623000793?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T12:34:32Z","timestamp":1757421272000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772724623000793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":17,"alternative-id":["S2772724623000793"],"URL":"https:\/\/doi.org\/10.1016\/j.dadr.2023.100209","relation":{},"ISSN":["2772-7246"],"issn-type":[{"value":"2772-7246","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of xylazine among people who inject drugs seeking medical care at a syringe services program clinic: Miami, Florida, 2023","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dadr.2023.100209","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100209"}}